MYH11 and thyroid gland carcinoma: In TC, among those over-expressed in males, we found PPARG, previously reported in thyroid carcinomas (Raman and Koenig, 2014), ERCC5, MYH11, LEMD2, ZNF133, and IDH1, the latter found to be mutated in thyroid carcinomas (Yang et al., 2012).